Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Plos Biology|September 8, 2020
In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and ageNicole A P Lieberman, Vikas Peddu, Hong Xie, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2020
<i>In vivo</i> antiviral host response to SARS-CoV-2 by viral load, sex, and ageNicole A P Lieberman, Vikas Peddu, Hong Xie, et al.
Msphere|July 28, 2021
Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific AntiviralsDebora Stelitano, Stuart P Weisberg, Monica P Goldklang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2022
Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington's diseaseGiuseppe Pepe, Luca Capocci, Federico Marracino, et al.
Mbio|June 1, 2021
Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the BrainCyrille Mathieu, Francesca T Bovier, Marion Ferren, et al.
Research Square|June 9, 2022
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infectionOlivier Reynard, Claudia Gonzalez, Claire Dumont, et al.
Nature Communications|October 28, 2022
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infectionOlivier Reynard, Claudia Gonzalez, Claire Dumont, et al.
Science (New York, N.Y.)|February 18, 2021
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferretsRory D de Vries, Katharina S Schmitz, Francesca T Bovier, et al.
Communications Biology|January 15, 2025
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunitySaid Mougari, Valérie Favède, Camilla Predella, et al.
Pageof 19